the suggestion of a drug for covid-19 with molecular docking

Background and objectives: this study aimed to study the interaction between the severe acute respiratory syndrome coronavirus 2 (sars‑cov‑2) spike protein complex and seven drugs that inhibit the angiotensin-converting enzyme 2. methods: plots of protein-ligand interaction were obtained using the ligplot software. in addition, binding energies in kcal/mol, hydrophobic interactions, and hydrogen bonds were determined. autodock software v.1.5.6 and autodock vina were used for the analysis of molecular docking processes.results: the only structure that interacted with the sars‑cov‑2 spike protein was anakinra. conclusion: anakinra was the only drug that interacted with the sars‑cov‑2 spike protein. this could be further investigated for finding a temporary alternative medicine for the treatment of coronavirus disease 2019.